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TranslocationThe type II diacylglycerol kinases (DGKs) contain several functional domains such as a pleckstrin homology
(PH) domain, two C1 domains and a sterile α-motif (SAM) domain. It was previously revealed that DGKδ
contributes to hyperglycemia-induced peripheral insulin resistance and thereby exacerbate the severity of
type 2 diabetes. Moreover, a high extracellular concentration of glucose activated DGKδ in skeletal muscle
cells, which was followed by a reduction in the intracellular diacylglycerol levels and the inactivation of pro-
tein kinase Cα, the enzyme that phosphorylates and inactivates the insulin receptor. However, the intracel-
lular behavior of DGKδ upon high glucose stimulation remains unclear. In this study, we found that DGKδ1,
but not a splice variant DGKδ2 or the other type II DGKη1/2, translocated from the cytoplasm to the plasma
membrane in human embryonic kidney HEK293 and mouse myoblast C2C12 cells within 5 min in response
to high glucose levels. The translocation was inhibited by phosphatidylinositol 3-kinase inhibitors, LY294002
and GDC-0941, suggesting that the event is regulated via the phosphatidylinositol 3-kinase pathway. More-
over, we revealed that the PH and C1 domains are responsible for the plasma membrane translocation and
that the SAM domain negatively regulates the translocation. These results indicate that DGKδ1 is the sole
type II DGK isoform that responds rapidly and dynamically to high glucose levels.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Upon stimulation by various hormones, growth factors, nutritional
signals and other agonists, a variety of signaling lipids that regulate a
wide range of biological output, are liberated or synthesized in the
cell. However, the cellular concentrations of such bioactive lipids
must be strictly regulated by the action of metabolic enzymes.
Diacylglycerol kinase (DGK) phosphorylates diacylglycerol to yield
phosphatidic acid [1–5], and diacylglycerol and phosphatidic acid
have been well recognized as lipid second messengers. Diacylglycerol
is known to be an activator of conventional and novel protein kinase
Cs (PKCs), chimaerins, Unc-13 and Ras guanyl nucleotide-releasing
protein [6–8]. Moreover, phosphatidic acid has been reported to
modulate the activities of phosphatidylinositol-4-phosphate kinase,
Ras GTPase-activating protein, Raf-1 kinase, atypical PKC and many
other important enzymes [9,10]. Thus, DGK appears to participate in
various physiological events by modulating the balance between
two bioactive lipids, diacylglycerol and phosphatidic acid, in the mi-
croenvironments within cells.kstrin homology; PKC, protein
orbol 13-acetate
).
l rights reserved.It is now recognized that DGK represents a large enzyme family:
the isoforms differ from each other remarkably with respect to their
structures, their modes of tissue expression and their enzymatic
properties [1–5]. Ten mammalian DGK isozymes (α, β, γ, δ, ε, ζ, η, θ, ι
and κ), which share common C1 and catalytic domains, are subdivided
into ﬁve groups according to other structural features [1–5].
The type II DGKs comprise δ [11], η [12] and κ [13] isozymes. More-
over, the alternative splicing products of DGKδ (δ1 and δ2) [14] and
DGKη (η1 and η2) [15] have been identiﬁed. All of the type II DGK
isoforms possess a pleckstrin homology (PH) domain at their N-termini
and a separated catalytic region, and DGKs δ1, δ2 and η2 contain a sterile
α-motif (SAM) domain at their C-termini. A tumor-promoting phorbol
ester, 12-O-tetradecanoylphorbol 13-acetate (TPA), induced the phos-
phorylation, oligomer–monomer conversion and translocation to the
plasma membrane of DGKδ1 [14,16,17]. On the basis of the analysis of
DGKδ-knockout mice, it has recently been reported that DGKδ regulates
epidermal growth factor [18,19] and insulin [20] receptor signaling by
modulating PKC activity. DGKδ contributes to hyperglycemia-induced
peripheral insulin resistance, thereby exacerbating the severity of type
2 diabetes [20]. Moreover, a high concentration of glucose activated
DGKδ, which caused a reduction in the intracellular diacylglycerol
levels and the removal of PKCα from the plasma membrane [21].
Therefore, DGKδ removes the tonic inhibition exerted by PKCα on in-
sulin receptor signaling and induces the transactivation of the insu-
lin receptor cascade leading to GLUT4 membrane translocation and
glucose uptake.
2211M. Takeuchi et al. / Biochimica et Biophysica Acta 1823 (2012) 2210–2216Further investigations are needed to understand in more detail the
molecular mechanisms underlying the regulation of the patho-
physiological functions of DGKδ with respect to its intracellular be-
havior upon high-glucose stimulation. In human embryonic kidney
HEK293 and mouse myoblast C2C12 cells, we found that DGKδ1, but
not DGKδ2, translocated from the cytoplasm to the plasmamembrane
via the phosphatidylinositol 3-kinase pathway in response to high
glucose levels. Moreover, it was revealed that the PH and C1 domains
of DGKδ1 are responsible for the glucose-induced plasma membrane
translocation.0 min 5 min 10 min
AcGFP-
a b c
A2. Materials and methods
2.1. Cell culture and transfection
HEK293 (a human embryonic kidney cell line), C2C12 (a mouse
myoblast cell line) and HeLa (a human epithelial carcinoma cell
line) cells were maintained in Dulbecco's modiﬁed Eagle's medium
(Wako Pure Chemicals) containing 10% fetal bovine serum at 37 °C
in an atmosphere of 5% CO2.
The HEK293, C2C12 and HeLa cells were transiently transfected
with plasmids using PolyFect (Qiagen) according to the instruction
manual. The cells were used for further analyses after 48 h of
transfection.30 min 60 min
0 min 5 min
 DGKδ1
d e
f g2.2. Plasmid constructs
cDNAs encoding amino acids 1–1170 (wild type (WT)), 1–1101
(ΔSAMD), 1–783 (ΔCCS–SAMD), 1–243 (PHD–C1D), 1–102 (PHD),
119–242 (C1D), 119–1170 (ΔPHD), 243–1170 (ΔPHD–C1D) and
119–1101 (C1D–CCS) of human DGKδ1 were ampliﬁed by PCR using
KOD-plus DNA polymerase (Toyobo). The products were inserted
into the EcoRI/SalI site of pAcGFP-C1D (Takara Bio-Clontech). The au-
thenticity of the constructs was conﬁrmed by DNA sequencing.AcGFP
  alone
B2.3. Confocal laser scanning microscopy
HEK293, C2C12 and HeLa cells grown on poly-L-lysine (Sigma-
Aldrich)-coated glass coverslips were transiently transfected with
pAcGFP-DGKδ1. After 3 h of glucose-starvation in glucose free medi-
um (20 mM HEPES-NaOH, pH 7.8, 120 mM NaCl, 5 mM KCl, 2.5 mM
MgSO4, 10 mM NaHCO3, 1.3 mM CaCl2, 1.2 mM KH2PO4, and 0.25%
bovine serum albumin [24]), the cells were treated with high glucose
(25 mM glucose in glucose free medium) for 5 min. The cells were
processed as described previously [22] and were examined using a
confocal laser-scanning microscope FV1000-D (Olympus). For immu-
noﬂuorescence microscopy, we used anti-DGKδ antibody (CT-1) [23]
and an immunoreaction enhancer solution (Can Get Signal® immu-
nostain, Toyobo).
To assess the extent of DGKδ translocation to the plasma mem-
brane, more than 20 cells were examined. The extent of translocation
was expressed as the percentage of cells exhibiting translocation.Fig. 1. Subcellular localization of DGKδ1 in HEK293 cells stimulated with high glucose.
(A) HEK293 cells were transfected with pAcGFP-DGKδ1 or pAcGFP-C1. After 48 h, the
cells were glucose-starved for 3 h and incubated with or without high glucose
(25 mM) for the indicated times. The cells were ﬁxed with 3.7% formaldehyde and ob-
served using confocal laser-scanning microscopy. Scale bar=10 μm. (B) The percent-
ages of the cells exhibiting the translocation of AcGFP-tagged DGKδ1-WT (closed
circle) or AcGFP alone (closed square) to the plasma membrane were scored. More
than 20 cells expressing AcGFP-tagged DGKδ1 or AcGFP alone were counted in each ex-
periment. The results are the means±S.D. of three independent experiments. The sta-
tistical signiﬁcance was determined using Student's t-test (***Pb0.005).2.4. Western blot analysis
Cell lysates were separated on SDS-PAGE. The separated proteins
were transferred to a polyvinylidene diﬂuoride membrane (Bio-Rad)
and blockedwith BlockAce (Dainippon Pharmaceutical). Themembrane
was incubatedwith anti-DGKδ antibody (WB-1) [23] for 1 h. The immu-
noreactive bands were visualized using peroxidase-conjugated anti-
rabbit IgG antibody (Jackson ImmunoResearch Laboratories) and ECL
(GE Healthcare Bio-Sciences).3. Results
3.1. DGKδ1 rapidly and transiently translocates to the plasma membrane
in response to high glucose
To analyze the intracellular behavior of DGKδ1 upon stimulation
with a high concentration of glucose, HEK293 cells expressing the iso-
form were treated with 25 mM glucose for 5, 10, 30 and 60 min. In
non-stimulated cells, DGKδ1 was diffusely distributed and partly local-
ized to punctate granules in the cytoplasm (Fig. 1A-a), whereas DGKδ1
was markedly translocated from the cytoplasm to the plasma mem-
brane in response to high-glucose stimulation for 5 min (Fig. 1A-b).
Quantitative analysis showed that the 5-min glucose treatment induced
an approximate 10-fold increase (from ~7% to ~72%) in the number of
cells exhibiting a distinct translocation of DGKδ1 to the plasma
A
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Fig. 2. Subcellular localization of DGKδ1 in HEK293 cells stimulated with high glucose
or xylose. (A) HEK293 cells were transfected with pAcGFP-DGKδ1. After 48 h, the cells
were glucose-starved for 3 h and incubated with or without high glucose (25 mM) and
xylose (25 mM) for 5 min. The cells were ﬁxed with 3.7% formaldehyde and observed
using confocal laser-scanning microscopy. Scale bar=10 μm. (B) The percentages of
cells exhibiting the translocation of AcGFP-tagged DGKδ1 to the plasma membrane
were scored. More than 20 cells expressing AcGFP-tagged DGKδ1 were counted in
each experiment. The results are the means±S.D. of three independent experiments.
The statistical signiﬁcance was determined using Student's t-test (*Pb0.05).
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Fig. 3. Subcellular localization of DGKδ1 in C2C12 cells stimulated with high glucose or
xylose. (A) C2C12 cells were transfected with pAcGFP-DGKδ1. After 48 h, the cells
were glucose-starved for 3 h and incubated with or without high glucose (25 mM)
and xylose (25 mM) for 5 min. The cells were ﬁxed with 3.7% formaldehyde and ob-
served using confocal laser-scanning microscopy. Scale bar=10 μm. (B) The percent-
ages of cells exhibiting the translocation of AcGFP-tagged DGKδ1 to the plasma
membrane were scored. More than20 cells expressing AcGFP-taggedDGKδ1were count-
ed in each experiment. The results are the means±S.D. of three independent experi-
ments. The statistical signiﬁcance was determined using Student's t-test (***Pb0.005).
2212 M. Takeuchi et al. / Biochimica et Biophysica Acta 1823 (2012) 2210–2216membrane (Fig. 1B). Moreover, the translocation of DGKδ1 occurred
rapidly, reaching a maximum by 5 min after glucose stimulation, and
then returned to the basal level within 30 min (Fig. 1A and B). We con-
ﬁrmed that the subcellular localization of AcGFP alone was not affected
by glucose stimulation (Fig. 1A-f,g and B). These results indicate that the
translocation occurs in a transient manner.
To evaluate the speciﬁcity of glucose, HEK293 cells expressing
DGKδ1 were treated with (25 mM) xylose for 5 min, though no vari-
ation occurred in the subcellular localization of DGKδ1 (Fig. 2), indi-
cating that the glucose effect was not due to changes in osmolarity.
Epidermal growth factor did not induce the plasma membrane trans-
location of DGKδ1 (data not shown), suggesting that the effect is
high-glucose selective.AcGFP-
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Fig. 4. Subcellular localization of DGKs δ1, δ2, η1 and η2 in HEK293 cells stimulated
with high glucose. (A) HEK293 cells were transfected with pAcGFP-DGKδ1, pAcGFP-
DGKδ2, pAcGFP-DGKη1 and pAcGFP-DGKη2. After 48 h, the cells were glucose-
starved for 3 h and incubated with or without high glucose (25 mM) for 5 min. The
cells were ﬁxed with 3.7% formaldehyde and observed using confocal laser scanning
microscopy. Scale bar=10 μm. (B) The percentages of cells exhibiting the transloca-
tion of AcGFP-tagged DGK isoforms to the plasma membrane were scored. More than
20 cells expressing AcGFP-tagged DGK isoforms were counted in each experiment.
The results are the means±S.D. of three independent experiments. The statistical sig-
niﬁcance was determined using Student's t-test (***Pb0.005).
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2213M. Takeuchi et al. / Biochimica et Biophysica Acta 1823 (2012) 2210–2216We conﬁrmed that the translocation of DGKδ1 from the cytoplasm
to the plasma membrane in response to high-glucose stimulation for
5 min was also notable in C2C12 myoblast cells, similar to the obser-
vation in HEK293 cells (Fig. 3); 25 mM xylose did not change the sub-
cellular localization of DGKδ1 in the C2C12 cells (Fig. 3). The HeLa
cervical cancer cells also showed the glucose-dependent plasma
membrane translocation of DGKδ1 (Suppl. Fig. 1). These results sug-
gest that the observed glucose-dependent plasma membrane translo-
cation is not restricted to one cell line.
3.2. Other type II isozymes, DGKs δ2, η1 and η2, fail to translocate to the
plasma membrane in the presence of high glucose
We next determined whether the other type II DGK isoforms, in-
cluding their splice variants (DGKδ2, DGKη1 and DGKη2), translocateC2
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Fig. 5. Subcellular localization of endogenous DGKδ in C2C12 cells stimulated with high
glucose. (A) Endogenous DGKδ1 and δ2 in C2C12 cells were detected by Western blot-
ting using anti-DGKδ antibody (WB-1). DGKδ1 and δ2 overexpressed in COS-7 cells
were also shown as a control. (B) C2C12 cells were glucose-starved for 3 h and incu-
bated with or without high glucose (25 mM) for 5 min. The cells were ﬁxed with
3.7% formaldehyde and then endogenous DGKδ was labeled with anti-DGKδ (CT-1)
and Alexa Fluor 488-coonjugated secondary antibodies. Normal rabbit IgG was used
as a negative control (lower panels). Cells were examined using confocal laser scan-
ning microscopy. Arrowheads indicate plasma membrane localization. Scale bar=
10 μm. (C) The percentages of cells exhibiting the translocation of DGKδ to the plasma
membrane were scored. More than 20 cells were counted in each experiment. The re-
sults are the means±S.D. of three independent experiments. The statistical signiﬁ-
cance was determined using Student's t-test (***Pb0.005).to the plasma membrane in response to high-glucose stimulation. As
shown in Fig. 4, DGKδ2, which localized to punctate granules in the
cytoplasm in resting cells, did not translocate to the plasma mem-
brane, even in the presence of 25 mM glucose. Moreover, both
DGKη1 and DGKη2 were diffusely localized in the cytoplasm and
failed to respond to the high-glucose stimulation. We previously
reported that DGKκ is localized at the plasma membrane, even in
resting cells [13]. Therefore, these results indicate that the high
glucose-dependent plasma membrane translocation is a δ1 isoform-
speciﬁc event among the type II DGKs.LY294002
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Fig. 6. Effects of LY294002 and GDC-0941 on the high-glucose-induced plasma mem-
brane translocation of DGKδ1. (A, C) HEK293 cells were transfected with pAcGFP-
DGKδ1 or pAcGFP-C1 vector. After being glucose-starved for 2.5 h and the subsequent
pretreatment with (A) 10 μM LY294002 (Sigma-Aldrich) or (C) 1 μM GDC-0941
(Selleck Chemicals) for 30 min, the cells were incubated with or without high glucose
(25 mM) for 5 min. The cells were ﬁxed with 3.7% formaldehyde and observed using
confocal laser-scanning microscopy. Scale bar=10 μm. (B, D) After treatment with
(B) LY294002 or (D) GDC-0941, the percentages of cells exhibiting the translocation
of AcGFP-tagged DGKδ1 to the plasma membrane were scored. More than 20 cells ex-
pressing AcGFP-tagged DGKδ1 were counted in each experiment. The results are the
means±S.D. of three independent experiments. The statistical signiﬁcance was deter-
mined using Student's t-test (**Pb0.01, ***Pb0.005).
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cells in response to high glucose
We next attempted to examine whether endogenous DGKδ translo-
cates to the plasma membrane in C2C12 cells in response to high glu-
cose. We conﬁrmed that both DGKs δ1 and δ2 were endogenously
expressed in C2C12 cells (Fig. 5A). In C2C12 cells, DGKδ2 was more
strongly expressed (the ratio of DGKδ2/DGKδ1=5.4±1.3 (n=3)).
When the cellswere treatedwith high glucose for 5 min, DGKδwaspart-
ly but clearly translocated to the plasma membrane (Fig. 5B and C). Be-
cause ectopically expressed DGKδ1, but not DGKδ2, was high glucose-
dependently translocated to the plasma membrane (Fig. 4), it is likely
that the high glucose-responsive, endogenous DGKδ isoform is DGKδ1.
As described above, only a small part of cellular DGKδ was translocated
to the plasma membrane (Fig. 5B). This result may be due to that, in ad-
dition to DGKδ1, DGKδ2, which does not response to high-glucose stim-
ulation (Fig. 4), was dominantly expressed in C2C12 cells (Fig. 5A).
3.4. High-glucose-dependent plasma membrane translocation of DGKδ1
is inhibited by phosphatidylinositol 3-kinase inhibitors, LY294002 and
GDC-0941
Because phosphatidylinositol 3-kinase was reported to act as a
downstream effector of high glucose [21,24], we next examined the
effects of phosphatidylinositol 3-kinase inhibitors, LY294002 and
GDC-0941, on the glucose-dependent plasma membrane transloca-
tion of DGKδ1. As shown in Fig. 6, both LY294002 and GDC-0941
markedly attenuated the high-glucose-dependent plasma membrane
translocation of DGKδ1, indicating that the event is positively regulat-
ed by phosphatidylinositol 3-kinase.
3.5. The PH and C1 domains play important roles in the plasma membrane
translocation of DGKδ1
We next attempted to identify the region(s) responsible for the
plasma membrane translocation of DGKδ1 upon glucose stimulation.
For this purpose, we constructed a series of deletion mutants, as illus-
trated in Fig. 7, and examined their subcellular localization. Compared
with wild-type DGKδ1 (Fig. 8A-a and B), the enzyme lacking the SAM
domain (DGKδ1-ΔSAMD) was more strongly localized to the plasma
membrane (Fig. 8A-b and B). DGKδ1-ΔCCS–SAMD, which further
lacks the coiled-coil structure-containing region, was also markedly
localized to the plasma membrane (Fig. 8A-c and B). A mutantWild Type
ΔSAMD
ΔCCS−SAMD
PHD−C1D
PHD
C1D
ΔPHD
ΔPHD−C1D
C1D−CCS
AcGFP
 alone
PHD C1D Catalytic Doma
Fig. 7. Schematic representation of the DGKδ1 mutants used and their translocation to the p
translocation of the DGKδ1 mutants to the plasma membrane. (+++, % translocation of DG
(See Fig. 8). †high glucose-independent translocation. PHD, PH domain; C1D, C1 domains; Ccontaining only the PH and C1 domains (DGKδ1-PHD–C1D) still
exhibited a translocation to the plasma membrane (Fig. 8A-d and
B), and the PH domain alone (DGKδ1-PHD) was weakly but clearly lo-
calized to the plasma membrane (Fig. 8A-e and B). In contrast, we ob-
served no translocation of the C1 domains alone (DGKδ1-C1D) to the
plasma membrane (Fig. 8A-f and B). These results strongly suggest
that the PH domain mainly contributes to the plasmamembrane trans-
location of DGKδ1 and that the C1 domain synergistically enhances the
action of the PH domain. The translocation of DGKδ1-ΔSAMD (Suppl.
Fig. 2A and C, and [16]), DGKδ1-ΔCCS–SAMD (data not shown),
DGKδ1-PHD–C1D (Suppl. Fig. 2B and D) and DGKδ1-PHD (data not
shown, refer to [16]) occurred in a glucose-independent manner, indi-
cating that the SAM domain negatively regulates the glucose-induced
translocation of DGKδ1. All of the mutants lacking the PH domain
(DGKδ1-ΔPHD, DGKδ1-ΔPHD–C1D, DGKδ1-C1D–CCS and DGKδ1-C1D)
failed to translocate to the plasma membrane (Fig. 8A-f–i and B),
supporting our conclusion that the PH domain plays a pivotal role in
the plasma membrane translocation of DGKδ1.4. Discussion
We previously reported that a non-physiological stimulation, TPA,
induced the plasma membrane translocation of DGKδ1 [14,16,17].
The present study demonstrated for the ﬁrst time that in human em-
bryonic kidney HEK293, mouse myoblast C2C12 cells and human ep-
ithelial carcinoma HeLa cells, DGKδ1 translocated from the cytoplasm
to the plasma membrane in response to a physiological stimulation:
high glucose (Figs. 1–3 and Suppl. Fig. 1). Moreover, endogenous
DGKδ was translocated to the plasma membrane in C2C12 cells in re-
sponse to high glucose (Fig. 5). Xylose did not induce this transloca-
tion (Figs. 2 and 3), indicating that the glucose effect was not due to
changes in the osmolarity. The glucose-dependent plasma membrane
translocation of DGKδ1 was observed in at least three cell lines
(Figs. 1–3 and Suppl. Fig. 1), suggesting that the translocation occurs
in a wide variety of cell lines.
DGKδ was found to contribute to hyperglycemia-induced peripheral
insulin resistance and type 2 diabetes [20]. Moreover, it was reported
that high glucose transiently activated DGKδwithin 5 min in L6 ratmyo-
blast cells [21]. The time course of the high-glucose-induced transloca-
tion of DGKδ1 to the plasma membrane (Fig. 1) correlates well with
that of the DGKδ activation [21]. However, in contrast to DGKδ1, the
DGKδ2 splice variant was localized to cytoplasmic granules (Fig. 4), as
previously shown [14], and did not response to high-glucose stimulation.in CCS SAMD
Translocation to the
 plasma membrane
†
†
†
†
lasma membrane. The numbers with “+” symbols and “–” represent the strength of the
Kδ1 mutants to the plasma membrane is 100–71%; ++, 70–41%; +, 40–11%; –, 10–0%)
CS, coiled-coil structures; SAMD, SAM domain.
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Fig. 8. Subcellular localization of the DGKδ1 mutants in the HEK293 cells stimulated
with high glucose. (A) HEK293 cells were transfected with pAcGFP-DGKδ1-WT,
pAcGFP-DGKδ1-ΔSAMD, pAcGFP-DGKδ1-ΔCCS–SAMD, pAcGFP-DGKδ1-PHD–C1D,
pAcGFP-DGKδ1-PHD, pAcGFP-DGKδ1-C1D, pAcGFP-DGKδ1-ΔPHD, pAcGFP-DGKδ1-
ΔPHD–C1D, pAcGFP-DGKδ1-C1D–CCS, and pAcGFP. After 2 days, the cells were
glucose-starved for 3 h and incubated with high glucose (25 mM) for 5 min. The
cells were ﬁxed with 3.7% formaldehyde and observed using confocal laser-
scanning microscopy. Scale bar=10 μm. (B) The percentages of cells exhibiting the
translocation of AcGFP-tagged DGKδ1 mutants to the plasmamembrane were scored.
More than 20 cells expressing the AcGFP-tagged DGKδ1 mutants were counted in
each experiment. The results are the means±S.D. of three independent experiments.
2215M. Takeuchi et al. / Biochimica et Biophysica Acta 1823 (2012) 2210–2216These results imply that DGKδ1 but not DGKδ2 is the high-glucose-
responding isoform. However, we cannot rule out the possibility that
DGKδ2 is also involved in the high-glucose-dependent signal transduc-
tion in a translocation-independent fashion.Because ectopically expressed DGKδ1, but not DGKδ2, was high
glucose-dependently translocated to the plasma membrane (Fig. 4),
it is likely that the high glucose-responsive, endogenous DGKδ iso-
form (Fig. 5B) is DGKδ1. We observed that endogenous DGKδ was
only partly translocated to the plasmamembrane in C2C12 cells in re-
sponse to high glucose (Fig. 5B). This result is probably due to that, in
addition to DGKδ1, DGKδ2, which was not translocated to the plasma
membrane in response to high-glucose stimulation (Fig. 4), was dom-
inantly expressed in C2C12 cells (Fig. 5A).
The plasma membrane translocation is a δ1 isoform-speciﬁc
event among type II DGKs (Fig. 4). Because it was reported that the
Pro/Asp/Glu-rich, DGKδ2-speciﬁc N-terminal region inhibited the plas-
ma membrane translocation of DGKδ2 in TPA-stimulated HEK293 cells
[14], the DGKδ2-speciﬁc N-terminal region of the isoform may inhibit
the high glucose-dependent translocation. Although DGKη1 and η2
were reported to translocate from the cytoplasm to cytoplasmic gran-
ules, including late endosomes, by stress stimulation such as osmotic
shock and oxidative stress [15], these isoforms were not responsible
for the high-glucose responses (Fig. 4). As previously reported, DGKκ
is localized to the plasmamembrane, even in resting cells [13]. The dis-
tinct stimulation dependencies and localizations of the type II DGK
isoforms imply that their different functions link to different signal
transduction pathways.
The high-glucose-dependent plasma membrane translocation was
signiﬁcantly attenuated by phosphatidylinositol 3-kinase inhibitors,
LY294002 and GDC-0941 (Fig. 6), suggesting that the event is posi-
tively regulated by phosphatidylinositol 3-kinase. DGKδwas reported
to transactivate the insulin receptor/phosphatidylinositol 3-kinase
pathway in L6 cells in response to high glucose stimulation [21].
Therefore, the translocation of DGKδ1 may be regulated by a feed-
forward mechanism.
We previously focused on the PH domain of DGKδ1 and showed
that the PH domain alone exhibited a weak localization to the plasma
membrane [14]. Interestingly, although the C1 domains alone did not
translocate to the plasma membrane, the PH domain coupled with
the C1 domains exhibited a strong localization to the plasma mem-
brane (Figs. 7 and 8), indicating that the PH domain synergistically
cooperated with the C1 domains. Recently, several PH domains
were reported to cooperate with other functional domains. For exam-
ple, the targeting of Tiam1 to the plasma membrane requires the co-
operative function of the N-terminal PH domain and an adjacent
protein interaction domain [25]. The interorganelle trafﬁcking of cer-
amide is regulated by the phosphorylation-dependent cooperativity
between the PH and START domains of CERT [26]. However, to our
knowledge, cooperation between a PH domain and a C1 domain has
not yet been reported. Several PH domains were reported to bind to
phosphatidylinositol 3-monophosphate, phosphatidylinositol 4,
5-bisphosphate and phosphatidylinositol 3, 4-bisphosphate [27].
However, an overlay assay did not provide positive results, indicat-
ing that the PH domain of DGKδ1 binds to the phosphoinositides
(data not shown). Kawasaki et al. reported that DGKδ associates with
clathrin and the adaptor protein 2 complex via the catalytic domain
[28]. However, it is likely that the high-glucose-dependent plasma
membrane translocation of DGKδ1 is regulated in a clathrin/adaptor
protein 2-independent manner because the PH and C1 domains are re-
sponsible for the event. Yet, the possibility remains that these proteins
negatively regulate the translocation of DGKδ1.We reported that recep-
tor for activated C kinase 1 interacts with DGKδ1 and δ2 [23]. However,
the relationship between the DGKδ1 translocation and the receptor is
unclear at present.
We previously reported that DGKη1 expressed in COS-7 cells was
translocated from the cytoplasm to punctate granules in response to
osmotic shock with 500 mM sorbitol [15]. Moreover, we recently re-
vealed that DGKη1 was redistributed from the cytosol to Nonidet
P-40-resistant membranes in response to osmotic shock (Matsutomo,
D., Isozaki, T., Sakai, H. and Sakane, F., unpublished work). In these
2216 M. Takeuchi et al. / Biochimica et Biophysica Acta 1823 (2012) 2210–2216cases, both the PH and C1 domains of DGKη1 are responsible for the
distribution to punctate granules and Nonidet P-40-resistant mem-
brane. Thus, it seems likely that the subcellular localization of the
type II DGK isoforms is commonly determined by the PH domain
and the C1 domains. The C1 domains of type I DGKs, DGKα [29] and
DGKγ [30] were reported to be involved in the translocation to the
plasma membrane and the nucleus, respectively. Thus, the C1 do-
mains in all DGKs may commonly act as the determinants of their
subcellular localization.
The molecular mechanisms of the high-glucose-dependent plasma
membrane translocation of DGKδ1 remain unclear.We are currently in-
vestigating the high-glucose-induced modiﬁcations of DGKδ1, includ-
ing phosphorylation and protein–protein interactions. Future studies
exploring themolecularmechanisms that regulate DGKδ1 translocation
may contribute to the understanding of the role of DGKδ in modulating
glucose uptake and type 2 diabetes pathogenesis.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamcr.2012.08.019.
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